Skip to content

LENZ Therapeutics has just received FDA approval for ‘VIZZ’

LENZ Therapeutics has just received FDA approval for ‘VIZZ’, a solution for presbyopia.
💧Only one daily dose of the drops is necessary for a dramatic improvement in near vision.
🕧The drops only take 30 minutes to work and deliver up to 10 hours of clarity.
📍The drops work by creating a pinhole effect without inducing myopic shift, also known as ‘pupil selective miotic mechanism.’
🍁Samples are due to be released in October, and full distribution is planned for mid-Q4 2025.